/

Treatment

Ayahuasca vs. Psilocybin Mushroom Retreats: The Ultimate Guide

Ayahuasca vs. Psilocybin Mushroom Retreats: The Ultimate Guide

,
The safety of both magic mushrooms and ayahuasca has stood the test of time, particularly alongside skilled and professional facilitation. Selecting a psychedelic retreat means honestly considering your personal preferences for the set and setting best suited for you.
Psychiatrist Survey Finds 'Striking Positive Shift in Attitudes Toward' Psychedelic Therapy

Psychiatrist Survey Finds ‘Striking Positive Shift in Attitudes Toward' Psychedelic Therapy

,
Psychiatrists in 2023 are much more optimistic about psychedelic-assisted therapy than they were in 2016
BrainFutures Releases Guide to Streamline Insurance Reimbursement for Psychedelic-Assisted Therapy

BrainFutures Releases Guide to Streamline Insurance Reimbursement for Psychedelic-Assisted Therapy

,
The cost of treatment protocols can be exorbitant, with the estimated cost of some treatments reaching up to $11,000.
TheraPsil Unveils MDMA-Assisted Psychotherapy Training Program

TheraPsil Unveils MDMA-Assisted Psychotherapy Training Program

The program is aimed at meeting the rising demand for training and treatment in MDMA therapy.
The Biggest Psychedelic News Stories of the Week - September 11th

The Biggest Psychedelic News Stories of the Week – September 11th

, ,
California stands on the cusp of a psychedelic revolution with the TREAT Act and a landmark bill on 'magic mushrooms,' even as Michigan, Congress, and global initiatives from Sweden to Canada expand the horizons of mental health, addiction treatment, and veteran care.
/6-of-the-best-psilocybin-retreats-in-jamaica-february-2023/

MDMA Successfully Treats PTSD in Another Phase 3 Trial Sponsored by MAPS

,
"MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024," says MAPS founder and president Rick Doblin.
The Millennium’s Primer Series: Neuroinflammation as a Barrier to the Success of Psychedelic-Assisted Therapies

The Millennium’s Primer Series: Neuroinflammation as a Barrier to the Success of Psychedelic-Assisted Therapies

,
Initial clinical trials into this exciting frontier have unveiled promising outcomes, showcasing remarkable improvements in clinical results using anti-inflammatory, nanoliposomal products prior to the application of a psychedelic agent.
The Risks of Mixing Psychedelics and Opioids for Chronic Pain

The Risks of Mixing Psychedelics and Opioids for Chronic Pain

The main risk of mixing psychedelics and opioids for chronic pain is an opioid overdose—a potentially life-threatening condition that should be treated as quickly as possible. Otherwise, it may result in coma, brain damage, and death.
First Psilocybin-Assisted Addiction Recovery Program in U.S. Opens in Oregon

First Psilocybin-Assisted Addiction Recovery Program in U.S. Opens in Oregon

Oregon pioneers the first Psilocybin-Assisted Addiction Recovery Program in the United States.

© 2023 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.